Profile
Kizoo Technology Capital is a venture capital firm based in Karlsruhe, Germany, established in 2000. The firm specializes in investing in rejuvenation biotechnology startups, focusing on innovative technologies that aim to prevent and reverse age-related diseases. Kizoo provides mentoring, seed, and early-stage financing to entrepreneurial teams dedicated to addressing the aging process.
The company's investment portfolio includes startups developing therapies in neurodegeneration, cardiovascular health, stem cell rejuvenation, and mitochondrial therapies. Notable projects include drugs targeting molecular damage associated with aging and approaches to rejuvenate aged stem cells. Kizoo also offers strategic support, leveraging the founders' extensive experience in both tech and biotech sectors to help startups navigate early-stage development and scale their innovations.
Kizoo's primary clients are young startup teams in the rejuvenation biotech field, with a mission to make a significant global impact on extending healthy human lifespans. The firm combines financial investment with mentoring to accelerate the growth of pioneering companies in this transformative area.